Additionally, overexpression of FBXO31 leads to reduced lipogenesis by inhibiting the activation of the AKT/mTOR signaling axis, thus preventing tumor growth and invasiveness in gliomas (33). This evidence concerns the gene FBXO31 and central nervous system cancer.